The synergistic effect of mefenamic acid with ionizing radiation in colon cancer
- 23 Downloads
Despite radiotherapy is an effective regimen in cancer treatment, resistance to tumor therapy still is a major challenge to radiotherapy and results in cancer recurrence and metastasis. Then the sensitization of tumor cells to ionizing radiation (IR) would be beneficial in cancer treatment. The aim of this study was to evaluate the synergistic effect of mefenamic acid (MEF) on colon cancer cell (HT-29) exposure to IR. HT-29 cells were treated with MEF and then exposed to IR. The synergistic effect of MEF is evaluated by clonogenic assay and flow cytometry. The productions of reactive oxygen species (ROS) were determined in irradiated and treated cells with MEF. The findings of this study showed that MEF had anti-cancer effect on colon cancer cell line and it increased the apoptosis in irradiated HT-29 cells. Also MEF reduced the number of cell colonies when HT-29 cells pre-treated with MEF and irradiated. MEF increased ROS production in irradiated cells. This additive effect of MEF with IR in killing of HT-29 cell was observed at low (10 μM) and medium (100 μM) concentrations of MEF. The present study demonstrates that MEF to be an additive effect on apoptosis and cell death induced by IR in colon cancer cells.
KeywordsMefenamic acid Synergistic, radiosensitizing Apoptosis Ionizing radiation
This study was supported by a grant from Mazandaran University of Medical Sciences, Sari, Iran.
SJH conceived and designed research. ZS, SKF, ZN, AG and HAO conducted experiments. SJH and HAO analyzed data. SJH wrote the manuscript. All authors read and approved the manuscript.
Compliance with ethical standards
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
All authors declare that they have no conflict of interest.
- Araujo MR, Campos LC, Damasceno KA, Gamba CO, Ferreira E, Cassali GD (2016) HER-2, EGFR, Cox-2 and Ki67 expression in lymph node metastasis of canine mammary carcinomas: association with clinical-pathological parameters and overall survival. Res Vet Sci 106:121–130. https://doi.org/10.1016/j.rvsc.2016.03.020 CrossRefGoogle Scholar
- Cho HJ, Ahn KC, Choi JY, Hwang SG, Kim WJ, Um HD et al (2015) Luteolin acts as a radiosensitizer in nonsmall cell lung cancer cells by enhancing apoptotic cell death through activation of a p38/ROS/caspase cascade. Int J Oncol 46(3):1149–1158. https://doi.org/10.3892/ijo.2015.2831 CrossRefGoogle Scholar
- Li S, Ma X, Ma L, Wang C, He Y, Yu Z (2013) Effects of ectopic HER-2/neu gene expression on the COX-2/PGE2/P450arom signaling pathway in endometrial carcinoma cells: HER-2/neu gene expression in endometrial carcinoma cells. J Exp Clin Cancer Res 32:11. https://doi.org/10.1186/1756-9966-32-11 CrossRefGoogle Scholar
- Mahadik M, Dhaneshwar S, Bhavsar R (2012) A high performance liquid chromatography-tandem mass spectrometric method for the determination of mefenamic acid in human plasma: application to pharmacokinetic study. Biomed Chromatogr 26(10):1137–1142. https://doi.org/10.1002/bmc.1755 CrossRefGoogle Scholar
- Soriano-Hernandez AD, Madrigal-Perez D, Galvan-Salazar HR, Martinez-Fierro ML, Valdez-Velazquez LL, Espinoza-Gomez F et al (2015) Anti-inflammatory drugs and uterine cervical cancer cells: antineoplastic effect of meclofenamic acid. Oncol Lett 10(4):2574–2578. https://doi.org/10.3892/ol.2015.3580 CrossRefGoogle Scholar
- Yazdannejat H, Hosseinimehr SJ, Ghasemi A, Pourfallah TA, Rafiei A (2016) Losartan sensitizes selectively prostate cancer cell to ionizing radiation. Cell Mol Biol (Noisy-le-grand) 62(1):30–33Google Scholar